Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Bicara Therapeutics Inc. has filed 245 SEC EDGAR filings since 10 Jun 2024

SEC filing history

Showing 176-200 of 245 matching filings.

Per page
25
Current page
8
S-8 File 333-286209

S-8

Filing date
28 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Mar 2025
Reporting date
14 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-42271

144 filing

Filing date
14 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-94620

SCHEDULE 13G filing

Filing date
03 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-94620

SCHEDULE 13G/A filing

Filing date
12 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94620

SC 13G

Filing date
26 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94620

SC 13G

Filing date
26 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-94620

SC 13D

Filing date
23 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Sep 2024
Reporting date
16 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-94620

SCHEDULE TO REPORT BENEFICIAL OWNERSHIP OF 5% OR MORE

Filing date
18 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Sep 2024
Reporting date
16 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94620

SC 13G filing

Filing date
18 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Sep 2024
Reporting date
16 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Sep 2024
Reporting date
16 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Sep 2024
Reporting date
17 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Sep 2024
Reporting date
12 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Sep 2024
Reporting date
12 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Sep 2024
Reporting date
12 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Sep 2024
Reporting date
16 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Sep 2024
Reporting date
12 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .